Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy (Q33737248)

29 July 2017

1 reference

title

Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy (English)

1 reference

29 July 2017

Valenta R

1

1 reference

29 July 2017

Vrtala S

2

1 reference

29 July 2017

Focke-Tejkl M

3

1 reference

29 July 2017

Bugajska-Schretter

4

1 reference

29 July 2017

Ball T

5

1 reference

29 July 2017

Twardosz A

6

1 reference

29 July 2017

Spitzauer S

7

1 reference

29 July 2017

Grönlund H

8

1 reference

29 July 2017

Kraft D

9

1 reference

29 July 2017

publication date

1 July 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

380

1 reference

29 July 2017

issue

7-8

1 reference

29 July 2017

page(s)

815-824

1 reference

Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Signal transduction by Fc receptors: the Fc epsilon RI case

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Fc epsilon RI on antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Four recombinant isoforms of Cor a I, the major allergen of hazel pollen, show different IgE-binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

SEROLOGICAL EVIDENCE OF IMMUNITY WITH COEXISTING SENSITIZATION IN A TYPE OF HUMAN ALLERGY (HAY FEVER).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Immunological and biological properties of Bet v 4, a novel birch pollen allergen with two EF-hand calcium-binding domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

The molecular basis for allergen cross-reactivity: crystal structure and IgE-epitope mapping of birch pollen profilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Early interleukin-4: its role in the switch towards a Th2 response and IgE-mediated allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

A mimotope defined by phage display inhibits IgE binding to the plant panallergen profilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Induction of both reaginic and blocking antibodies with a low molecular weight fraction of timothy pollen extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Studies on allergoids from naturally occurring allergens III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Contribution of disulphide bonds to antigenicity of Lep d 2, the major allergen of the dust mite Lepidoglyphus destructor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Engineering of hypoallergenic mutants of the Brassica pollen allergen, Bra r 1, for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Genetically engineered plant allergens with reduced anaphylactic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Molecular cloning and immunological characterisation of Cyn d 7, a novel calcium-binding allergen from Bermuda grass pollen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Isoforms of Bet v 1, the major birch pollen allergen, analyzed by liquid chromatography, mass spectrometry, and cDNA cloning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Recombinant allergens for immunoblot diagnosis of tree-pollen allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Diagnosis of grass pollen allergy with recombinant timothy grass (Phleum pratense) pollen allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Recombinant allergens for diagnosis and therapy of allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Immunological and structural similarities among allergens: prerequisite for a specific and component-based therapy of allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

The immunoglobulin E-allergen interaction: a target for therapy of type I allergic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Molecular and structural analysis of a continuous birch profilin epitope defined by a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Immunotherapy of allergy: anergy, deletion, and immune deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

IgE-mediated allergen presentation via Fc epsilon RI on antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

Expression of ɛ germ-line gene transcripts and mRNA for the ɛ heavy chain of IgE in nasal B cells and the effects of topical corticosteroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.1999.101

21 January 2018

Identifiers

DOI

10.1515/BC.1999.101

1 reference

29 July 2017

1 reference